Celcuity
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.About CELC
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.
CELC Key Statistics
Stock Snapshot
The current Celcuity(CELC) stock price is $105.80, with a market capitalization of 4.9B. The stock trades at a price-to-earnings (P/E) ratio of -28.84.
As of 2025-12-05, Celcuity(CELC) stock has fluctuated between $105.00 and $107.78. The current price stands at $105.80, placing the stock +0.8% above today's low and -1.8% off the high.
Celcuity(CELC) shares are trading with a volume of 524.6K, against a daily average of 844.9K.
In the last year, Celcuity(CELC) shares hit a 52-week high of $107.78 and a 52-week low of $7.58.
In the last year, Celcuity(CELC) shares hit a 52-week high of $107.78 and a 52-week low of $7.58.
CELC News
New insider activity at Celcuity ( (CELC) ) has taken place on December 3, 2025. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insig...
Key Points San Diego-based Tang Capital Management bought nearly 1.2 million CELC shares. The move helped increase the fund's reported holdings in CELC by $56...
Celcuity Inc. recently completed and submitted a New Drug Application to the FDA for gedatolisib, targeting hormone receptor positive, HER2-negative advanced br...
Analyst ratings
90%
of 10 ratingsMore CELC News
Curious if Celcuity is living up to all the buzz? Let’s take a closer look at whether its current share price really makes sense or if there is more here than f...
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention. New York City-based Apis Capital Advisors...
